NasdaqCM - Nasdaq Real Time Price USD
Iterum Therapeutics plc (ITRM)
Tune into live earnings calls Now streaming directly on quote pages.
1.0200
-0.0300
(-2.86%)
At close: May 9 at 4:00:00 PM EDT
1.0500
+0.03
+(2.94%)
After hours: May 9 at 7:50:21 PM EDT
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 1 | 1 | 1 | 2 |
Avg. Estimate | -- | -- | 9.33M | 17.27M |
Low Estimate | -- | -- | 9.33M | 15.1M |
High Estimate | -- | -- | 9.33M | 19.45M |
Year Ago Sales | -- | -- | -- | 9.33M |
Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 85.10% |
Earnings History
Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
---|---|---|---|---|
EPS Est. | -0.54 | -0.5 | -0.21 | -0.24 |
EPS Actual | -0.38 | -0.23 | -0.24 | -0.12 |
Difference | 0.16 | 0.27 | -0.03 | 0.12 |
Surprise % | 29.63% | 54.00% | -14.29% | 50.00% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
ITRM | -- | -- | -- | -- |
S&P 500 | 12.66% | 3.22% | 7.99% | 13.82% |
Upgrades & Downgrades
Maintains | HC Wainwright & Co.: Buy to Buy | 8/15/2024 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 6/21/2024 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 5/31/2024 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 5/14/2024 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 4/30/2024 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 4/1/2024 |
Related Tickers
MIST Milestone Pharmaceuticals Inc.
1.1100
-7.50%
SPRO Spero Therapeutics, Inc.
0.6200
+7.83%
SLS SELLAS Life Sciences Group, Inc.
1.5600
-7.14%
ALLR Allarity Therapeutics, Inc.
1.0500
-1.87%
ZVSA ZyVersa Therapeutics, Inc.
0.5272
-7.70%
PHIO Phio Pharmaceuticals Corp.
1.7600
-2.22%
LXRX Lexicon Pharmaceuticals, Inc.
0.7010
+1.73%
CTMX CytomX Therapeutics, Inc.
0.9284
-14.83%
CNTB Connect Biopharma Holdings Limited
0.8098
+1.23%
GLMD Galmed Pharmaceuticals Ltd.
1.2400
-0.80%